2023Q1营收归零,继续亏损,目前看不到投资价值。查看全文
美股律师郝俊波2021-06-09 17:18
$AcelRx制药(ACRX)$ 【AcelRx Pharmaceuticals Inc(ACRX)证券诉讼信息 】
AcelRx Pharmaceuticals Inc(ACRX)因证券欺诈案已经于近日被投资者诉至法院。在目前的诉讼中投资者指控该公司在2020年3月17日至2021年2月12日期间就公司的业务、运营及合规问题进行虚假陈述,未向投资者披露以下重大不...查看全文
$AcelRx制药(ACRX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-23-008737 Act: 34 Size: 12 MB 网页链接
$AcelRx制药(ACRX)$ 8-K Current report, items 2.02, 4.02, and 9.01 Accession Number: 0001437749-23-008621 Act: 34 Size: 358 KB 网页链接
$AcelRx制药(ACRX)$ 8-K Current report, items 1.01, 1.02, and 9.01 Accession Number: 0001437749-23-006898 Act: 34 Size: 171 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-016330 Size: 4 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-016311 Size: 4 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-016316 Size: 4 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-016324 Size: 4 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-009123 Size: 9 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-009127 Size: 9 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-009131 Size: 9 KB 网页链接